Product
LUM/IVA
Aliases
lumacaftor/ivacaftor, Lumacaftor/Ivacaftor, VX-809/VX-770
2 clinical trials
1 indication
Indication
Cystic FibrosisClinical trial
An Exploratory Phase 2, 2-part, Randomized, Double-blind, Placebo-controlled Study With a Long-term, Open-label Period to Explore the Impact of Lumacaftor/Ivacaftor on Disease Progression in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for F508delStatus: Completed, Estimated PCD: 2020-10-09